Trim 10-15% IBM at market; preserve floor through Q3 earnings binary with defined re-entry
Underweight IBM with 10-15% immediate trim at market. Structural negatives (1.1% organic growth, $67.7B goodwill at 35% of market cap, 12.6% effective tax rate flattery, failed $247 breakouts, Fed hike environment, 95% no-cut probability) remain documented and unchallenged. The 9/15 Hold produced -3.9% alpha on this exact configuration — repeat posture invites repeat loss. Execute at market immediately (do not stage at $240-242 overhead resistance per 8/20/8/25 directives); the bearish view says retracement to those levels is unlikely. Preserve $215 close-only stop on residual; do not use $228 stop per Conservative Analyst (structurally inconsistent with their own $228-230 BUY zone). Maintain foundry/HashiCorp/Q3 earnings binary upside optionality through explicit re-entry triggers rather than full exit. Apply macro hedge via TLT puts. Income mandates exempt from trim. Price target 220.0.
| Position | Action |
|---|---|
| Total-return mandates | Trim 10-15% of IBM position immediately at market to reduce gross exposure |
| Income mandates | Maintain full position; do not trim; the 2.72% dividend yield justifies holding |
| Residual position after trim | Apply close-only stop at $215 on remaining IBM exposure |
IBM's $1B government co-funded Anderon quantum foundry creates a vertically integrated moat as America's only domestic quantum chip foundry, while ongoing margin expansion from 13.5% to 18.5% and 2.72% dividend yield provide defensive characteristics in hawkish macro regimes—making the current price a generational entry point.
| Indicator | Value | Signal |
|---|---|---|
| Close | 237.49 | neutral |
| 50 SMA | 234.03 | bullish |
| 200 SMA | 257.23 | bearish |
| 10 EMA | 239.78 | bearish |
| RSI (14) | 50.28 | neutral |
| MACD | 1.99 | neutral |
| MACD Signal | 0.75 | neutral |
| MACD Histogram | 1.24 | neutral |
| Bollinger Middle | 236.34 | neutral |
| Bollinger Upper | 247.00 | bearish |
| Bollinger Lower | 225.69 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close above $247 on volume >6M with one full session of follow-through
Then: Re-enter trimmed exposure on momentum confirmation
The $1B Anderon quantum foundry is a multi-year moat construction event, not a sell-the-news event
↩ rebuts: “Bear's claim that 3% stock decline after announcement means sell-the-news”
EV: +8–15% near-term upside to $247–257; +25%+ 12-month upside to $280+ · concedes: Existing holders should HOLD but not trim; Don't go all-in with reckless size; The 5-day relative strength could reverse if broader market continues to sell off; Q2 2026 revenue growth of +1.1% is real and needs Q3/Q4 recovery to validate thesis
IBM is priced as a quantum/AI transformation story while delivering 1% organic revenue growth on a balance sheet with 189% leverage and $67.7B in goodwill; multiple compression will drive the stock to $170–$190.
· concedes: A breakout above $247 on heavy volume would invalidate the range-bound thesis and force a re-evaluation; Red Hat is a real business (though growing low single digits); Operating margin did expand 500bps in 3 years (though 200bps came from below-normal tax rates and cost cuts)
→ vs conservative: Conservative treatment of IBM as a 'busted value trap' ignores $1 billion federal foundry commitment and 500 bps margin expansion; 189% debt-to-equity is manageable with $11.5B annual FCF and 110-year dividend history; waiting at 237 for 228-230 turns a 30% move into 10%
→ vs conservative: The failed September 14 breakout framing misses the current coiling pattern with 50 SMA support, which typically resolves in direction of underlying catalyst rather than returning to middle
→ vs neutral: Neutral 'wait for confirmation' approach (247 breakout on volume, capitulation at 228, Q3 October earnings) leads to whipsawing and never getting positioned; tape is already providing confirmation via 6% 5-day outperformance
→ vs neutral: Trading at Hold is tactically correct but intellectually wrong; should be accumulating into strength, not preparing for breakdown that data increasingly doesn't support
→ vs neutral: Rating this as 'coin flip' misprices the foundry option value, misprices the 0.71 beta as macro hedge, and misprices the dividend floor
| ATR (14) | 7.58 | neutral |
| VWMA (30) | 237.69 | neutral |
| Volume | 6,162,340 | bearish |
Support: 234.03 · 225.69 · 209.7 · 197.77 | Resistance: 247 · 249.09 · 257.23
IBM closed at 237.49, sitting 7.7% below the 200 SMA at 257.23, confirming a bearish long-term regime. The 50 SMA at 234.03 provides first-line support; a close below it would weaken the medium-term cautiously supportive thesis. The short-term 10 EMA at 239.78 sits above price, reflecting the two-day reversal from the Sep 14 high of 249.09 back to current levels. Momentum is neutral with RSI at 50.28 and a modestly positive but contracting MACD histogram of 1.24. The upper Bollinger Band at 247.00 was rejected twice in mid-September, suggesting distribution at that level, while today's close just above the middle band at 236.34 indicates consolidation. Volume of 6.16M (elevated vs. 4.6M 30-day average) on the down day signals distribution pressure. ATR of 7.58 implies moderate daily volatility suitable for swing trading with stops placed roughly 2x ATR from entry. The overall technical picture is range-bound with downside bias, awaiting a decisive break of either 234 (bearish breakdown) or 247 (bullish breakout) to define the next directional move.
Market Cap
$223.75B
P/E (TTM)
21.11x
Forward P/E
18.04x
PEG Ratio
2.36
P/B (Price to Book)
6.49x
EPS (TTM)
$11.25
Forward EPS
$13.16
Dividend Yield
2.72%
Beta
0.708
52-Week High
$332.46
52-Week Low
$199.19
50-Day Moving Average
$236.16
200-Day Moving Average
$260.68
Gross Margin (TTM)
58.1%
Operating Margin (TTM)
16.5%
Net Margin (TTM)
15.5%
EBITDA Margin (TTM)
~23.8%
ROE (Return on Equity)
34.5%
ROA (Return on Assets)
5.3%
Free Cash Flow (TTM)
$12.05B
FCF Margin
17.4%
Dividends Paid (2025)
$6.26B
Operating Cash Flow (2025)
$13,193M
Capital Expenditure (2025)
$1,738M
Free Cash Flow (2025)
$11,455M
Acquisitions (2025)
$8,295M
Total Debt
$64.61B
Net Debt
$47.67B
Cash & Equivalents
$14,417M
Debt/Equity
189%
Current Ratio
0.79
Goodwill
$67.72B
Total Assets (2025)
$151,880M
Stockholders' Equity (2025)
$32,648M
Revenue (2025)
$67,536M
Revenue (2024)
$62,753M
Revenue (2023)
$61,860M
Revenue (2022)
$60,530M
Net Income (2025)
$10,593M
Net Income (2022)
$1,640M
Diluted EPS (2025)
$11.17
Diluted EPS (2022)
$1.80
Operating Income (2025)
$12,492M
Operating Income (2022)
$8,174M
R&D Spend (2025)
$8.32B
Revenue Growth (Q2 2026 YoY)
+1.1%
Diluted EPS (Q2 2026)
$2.27
Effective Tax Rate (Q2 2026)
~12.6%
Working Capital (2025)
($1,714)M
Q1 2026 Unusual Charge
$445M
Strengths
Concerns
IBM is a mature, financially mature enterprise in strategic transition toward hybrid cloud and AI services, with a TTM P/E of 21.11x and market cap of $223.75B. The company has demonstrated impressive operational improvement with operating margins expanding 500 bps over three years to 18.5% in 2025, driving EPS from $1.80 to $11.17 (+520%), while generating substantial free cash flow of approximately $11.5B annually that supports its century-old dividend. However, significant balance sheet risks persist including a 189% Debt/Equity ratio, negative working capital (current ratio 0.79), and $67.72B in goodwill from aggressive M&A, while recent quarterly revenue growth has decelerated to just 1.1% YoY in Q2 2026, suggesting the AI transformation has not yet delivered meaningful top-line acceleration.
Macro: Fed decision day (Wed Sep 16) triggered a -600 pt Dow/broad S&P 500 and Nasdaq decline after the Fed hiked rates while bond yields rose. Polymarket 'No Fed rate cuts in 2026' is at 95% probability ($8.37M volume, +1.9pp week-over-week). Polymarket 'US recession by end of 2026' is at 12% probability (+4.0pp WoW) — firmly in soft-landing territory. Treasury 10-year sits below 5% in a notable bull-flattener (hike delivered but long end lower), implying the market believes the hike is growth-dampening rather than a new tightening cycle. Dimon commentary: 'It's not clear to me we've slayed inflation.' FRED macro data unavailable due to missing API key.